GENE ONLINE|News &
Opinion
Blog

Novartis
Deals Oncology Market
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Ranking & Reports NovartisQ2 Report
Novartis Achieves 11% Sales Growth with Strong Performance in Heart Failure, Immune Drugs, and R&D in Q2
2024-08-06
Trials & Approvals CAR-T therapyCAR T-cell Therapy
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
JPM 2024 Global EventsDrug Price NegotiationDigital Healthcare
JPM 2024: More Noteworthy Industry Stories and Updates of Long-rumored Cytokinetics Acquisition
2024-01-15
JPM 2024 JPMJP Morgan 2024
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
2024-01-10
Asia-Pacific partnershipBiosimilar
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
Feature FDA ApprovalGene and Cell Therapy
GeneOnline’s Weekly News Highlights: July 31-Aug 4
2023-08-07
M&A Neuromuscular Disorder
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
Special biomedicalHealthcare
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
M&A acquisitionNovartis
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Partnerships Novartis
Novartis Lays Down $40 Million for 3BP’s FAP-Targeting Oncology Tech
2023-04-24
Trials & Approvals Breast Cancer
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Trials & Approvals brain cancer
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Regulatory Gene Therapy
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Special JPM
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
1 2 3 … 7
LATEST
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
Healthcare Revolution: Leeuwenhoek Joins Hands with Key Companies and Experts at Healthcare+ Expo Taiwan 2024
2024-12-11
2024 Taiwan Healthcare+ Expo: Innovations in Five Key Industries
2024-12-11
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top